Nachrichten zur Johnson Matthey PLC Aktie

Johnson & Johnson: Dividend Legend At A Discount

…

Standard Investments Sends Open Letter to Johnson Matthey

Standard Investments, the largest investor in Johnson Matthey Plc ("JM" or the "Company") with an economic interest in approximately 11.01%…

Johnson & Johnson (JNJ) Stock Declines While Market Improves: Some Information for Investors

In the most recent trading session, Johnson & Johnson (JNJ) closed at $143.85, indicating a -1.89% shift from the previous…

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what…

[Latest] Global Dry Eye Syndrome Treatment Market Size/Share Worth USD 12,281.4 Million by 2033 at a 7.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

Johnson & Johnson Aktie: Citigroup senkt Kursziel - trotzdem ein Kauf?

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Citigroup: Aktuelle Bewertung Die US-Bank Citigroup hat das Kursziel für Johnson & Johnson…

Top Analyst Reports for Home Depot, Johnson & Johnson & Salesforce

Todays Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Johnson & Johnson…

3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later

You dont have to be an income investor to like dividends. Many billionaires who definitely dont need income still have…

How To Build A $25,000 Dividend Portfolio, Johnson & Johnson As Your Core Holding

…

Johnson Matthey Plc (JMPLF) Q2 2025 Earnings Call Transcript

…

2 Very Healthy Dividend Stocks to Hold for Decades of Income

Checking a companys vital signs before investing in its stock for dividend income is essential. If the underlying company isnt…

Dr. Oz Held Millions In Healthcare Investments, Raising Potential Conflicts For Medicare And Medicaid

The celebrity doctor’s 2022 financial disclosure for his Senate run details holdings in stocks like UnitedHealth, CVS and Johnson &…

Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive

…

Johnson & Johnson (JNJ) Management presents at Stifel 2024 Healthcare Conference (Transcript)

…

Johnson & Johnson: Tracking Well Above The Industry

…

Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma

If approved, daratumumab will become the first treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple…

The Zacks Analyst Blog Highlights Amazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction

mazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction are part of the Zacks top Analyst Blog.…

Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific

Todays Research Daily features new research reports on 12 major stocks, including Amazon.com, Inc. (AMZN), Johnson & Johnson (JNJ) and…

If You Invested $10,000 In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?

Johnson & Johnson (NYSE:JNJ) researches, develops, manufactures and sells various products in the health care field worldwide. It is set…

This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lillys Stock

Fewer contenders means fewer constraints on expanding market share.…

This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lillys Stock @themotleyfool #stocks $JNJ $LLY $BIIB

Fewer contenders means fewer constraints on expanding market share.…

Johnson & Johnson Aktie: MedTech hat Rückenwind

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi

Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi are included in this Analyst Blog.…

Kenvue shares surge after activist Starboard takes stake

Starboard Value has amassed a significant stake in Kenvue, which spun out of Johnson & Johnson in mid-2023.…

Johnson & Johnson Aktie: Neues Kursziel

New York (www.aktiencheck.de) - Rating-Update: Joanne Wuensch, Analystin der Citigroup, bewertet die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046, WKN:…

Passives Einkommen: Zuverlässige Dividendenerträge? Hier sind Anleger bestens aufgehoben!

Kaum ein Unternehmen schüttet so sicher Dividenden aus wie Johnson & Johnson. Und seit 62 Jahren steigen sie kontinuierlich und…

Johnson & Johnson: Q3 Earnings Highlights Resilience And New Growth

…

Johnson & Johnson Aktie: Kurszielerhöhung nach starkem Q3-Ergebnis

Toronto (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von RBC Capital Markets: Rating und Kursziel RBC Capital Markets hat das Kursziel für Johnson &…

Johnson & Johnson Aktie: Pharma-Sparte übertrifft Erwartungen - Kursziel angehoben!

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Morgan Stanley: Morgan Stanley erhöht Kursziel auf 175 USD Der Analyst Terence Flynn von…

ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike

Johnson & Johnson infused positive optimism after posting solid third-quarter 2024 earnings. A few analysts raised their target price on…

Verhaltene Kauflaune bei Johnson & Johnson-Aktie (151,4853 €)

Am US-amerikanischen Aktienmarkt ist der Anteilsschein von Johnson & Johnson aktuell unauffällig. Das Papier kostete zuletzt 164,46 US-Dollar. Kaum auffällig…

Johnson & Johnson Aktie: Solide Geschäftsfundamente - Kursziel angehoben!

St. Louis (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Stifel: Stifel hat das Kursziel für Johnson & Johnson (ISIN: US4781601046, WKN: 853260,…

Johnson & Johnson Aktie: Optimistischer Ausblick für 2025 trotz verhaltener Q4-Wachstumsprognose

San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo Advisors: Wells Fargo hat das Kursziel für Johnson & Johnson (ISIN:…

Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript

JNJ earnings call for the period ending September 30, 2024.…

Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript

…

Johnson & Johnson Q3: Strengthening Cardiovascular Device Portfolio

…

4 stocks to watch on Tuesday: BAC, JNJ and more

Bank of America (BAC), Goldman Sachs (GS), Johnson & Johnson (JNJ) and UnitedHealth (UNH) are the stocks to watch on…

Bank earnings, Nvidia record high, oil prices sink: 3 Things

US stock futures (ES=F, NQ=F, YM=F) are flat Tuesday morning coming off the Dow Jones Industrial Average (^DJI) and S&P…

J&J beats Q3 earnings estimates, raises full-year sales guidance

Johnson & Johnson (NYSE:JNJ) shares moved higher after the pharmaceutical giant posted better-than-expected results for the third quarter. Earnings per...…

Johnson & Johnson: Ergebnisprognose gekappt – das ist der Grund

Die Berichtssaison in den USA nimmt peu à peu an Fahrt auf. Traditionell gehört Johnson & Johnson neben den großen…

Johnson & Johnson reports Q3 beat, raises sales guidance By Investing.com

Johnson & Johnson reports Q3 beat, raises sales guidance…

United Health, Johnson & Johnson lead Tuesdays earnings lineup By Investing.com

United Health, Johnson & Johnson lead Tuesdays earnings lineup…

Cramers week ahead: Major banks, Taiwan Semi and Netflix report as earnings season gets into full swing

Charles Schwab, Bank of America, Johnson & Johnson, Walgreens, UnitedHealth Group Morgan Stanley, Procter & Gamble and Abbott Laboratories all…

J&J discontinues dengue drug study after changes in R&D portfolio

Johnson & Johnson said it will discontinue a mid-stage field study evaluating the efficacy of its experimental pill for the…

Johnson & Johnson discontinues dengue drug study By Reuters

Johnson & Johnson discontinues dengue drug study…

Wells Fargo says there is a risk that Johnson & Johnson will guide lower By Investing.com

Wells Fargo says there is a risk that Johnson & Johnson will guide lower…

Johnson & Johnson investing $2 billion in new manufacturing plant in Wilson, Cooper says

Johnson & Johnsons new facility will create 420 jobs in Wilson County.…

J&J to invest more than $2 billion in new manufacturing facility

Johnson & Johnson said on Tuesday it will invest more than $2 billion to build a new manufacturing facility at…

Johnson & Johnson-Aktie: Kurs nur geringfügig im Minus (144,7813 €)

Der Kurs der dem Anteilsschein von Johnson & Johnson kommt kaum von der Stelle. Der jüngste Kurs betrug 161,13 US-Dollar.…

2 Excellent Dividend Stocks to Buy With Less Than $200

Abbott Laboratories and Johnson & Johnson both have raised their dividends annually for more than 50 years.…